biotech · Type 1 Diabetes · Coronavirus · SABS
SAB Biotherapeutics
SAB Biotherapeutics is a biotech organization headquartered in Gaithersburg, USA. It trades on NYSE under ticker SABS. Primary therapeutic focus areas include Type 1 Diabetes, Coronavirus, Influenza A H1N1, Influenza Typ
Gaithersburg, USA HQ
2016 Founded
39 Employees
Public company Type
SABS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Gaithersburg, USA
- Founded
- 2016
- Employees
- 39
- Programs
- 8
- Drugs
- 10
- Patents
- 1
Single Ascending Dose of SAB-176
Phase 1 · small molecule · PHA1A
Single Ascending Dose of SAB-176 for PHA1A is a Phase 1 program (small_molecule) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Internal code SAB-176-103
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- SAB Biotherapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- PHA1A
- Status
- active
- Trials
- 1